Larex Studies Effect of Arabinogalactan on Pediatric Immune SystemLarex Studies Effect of Arabinogalactan on Pediatric Immune System

Larex Studies Effect of Arabinogalactan on Pediatric Immune System

WHITE BEAR LAKE, Minn.--Larex Inc. conducted a clinical study to determine the potential stimulatory effect of larch arabinogalactan on the pediatric immune system. Larch arabinogalactan, a natural compound found in the Larix genus of trees, has been shown to stimulate the human immune response in adults. A number of immune system boosters have entered the market in recent years; however, most have not been evaluated in clinical trials with pediatric populations.

The 12-week study was conducted at Health East Care System and included 507 children, ages three to 12. Of the 507 children, 337 consumed 3 g of larch arabinogalactan in a juice drink twice a day; 168 of these children also consumed vitamins with arabinogalactan in their juice. More than 90 percent of the children completed the study, and researchers found that larch arabinogalactan was well-tolerated by this age group. Children, ages 7 to 9 years, who consumed larch arabinogalactan exhibited a lower duration and number of illness episodes compared to the other treatment groups. No other significant treatment-related effects were observed.

For more information, visit www.larex.com or Booth #1541-1543 at SupplySide West.